Specific molecular targets to control tropical diseases

Chagas' disease or American trypanosomiasis is considered by the Word Health Organization to be one of the important tropical parasitic diseases worldwide together with malaria and schistosomiasis. The etiologic agent of this illness is the kinetoplastid protozoon Trypanosoma cruzi. The present...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Rodriguez, J.B
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2001
Materias:
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 12367caa a22017177a 4500
001 PAPER-20603
003 AR-BaUEN
005 20230518205200.0
008 190411s2001 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0034945049 
024 7 |2 cas  |a Antiprotozoal Agents 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a CPDEF 
100 1 |a Rodriguez, J.B. 
245 1 0 |a Specific molecular targets to control tropical diseases 
260 |c 2001 
270 1 0 |m Rodriguez, J.B.; Dept. de Química Organica, Facultad Ciencias Exactas Naturales, Universidad de Buenos Aires, Pabellón 2, RA-1428 Buenos Aires, Argentina; email: JBR@qo.fcen.uba.ar 
506 |2 openaire  |e Política editorial 
504 |a (1991), Anonymous. Control of Chagas' Disease. Geneva, World Health Organization, WHO Technical Report Series, No. 811; Moncayo, A., (1993), pp. 67-75. , In Eleventh Programme Report of the UNPD/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR), World Health Organization, Geneva; Burleigh, B.A., Andrews, N.W., (1995) Annu. Rev. Microbiol., 49, pp. 175-200 
504 |a Brener, Z., (1973) Annu. Rev. Microbiol., 27, pp. 347-382 
504 |a De Souza, W., (1984) Int. Rev. Cytol., 86, pp. 197-283 
504 |a Kirchhoff, L.V., (1993) New Engl. J. Med., 329, pp. 639-644 
504 |a Galel, S.A., Kirchhoff, L.V., (1996) Transfusion, 36, pp. 227-231 
504 |a Shulman, I.A., Appleman, M.D., Saxena, S., Hiti, A.L., Kirchhoff, L.V., (1997) Transfusion, 37, pp. 727-731 
504 |a De Castro, S.L., (1993) Acta Tropica, 53, pp. 83-98 
504 |a Cançado, J.R., Brener, Z., (1979), pp. 362-424. , In Trypanosoma cruzi e Doença de Chagas. Brener, Z., Andrade, Z. Eds, Guanabara Koogan, Sao Paulo; Brener, Z., (1979) Pharmacol. Ther., 7, pp. 71-90 
504 |a Schmuñis, G.A., Szarfman, A., Coarasa, L., Guilleron, C., Peralta, J.M., (1980) Am. J. Trop. Med Hyg., 29, pp. 170-178 
504 |a Marr, J.J., Docampo, R., (1986) Rev. Infect. Dis., 8, pp. 884-903 
504 |a Rodriguez, J.B., Gros, E.G., (1995) Curr. Med. Chem., 2, pp. 723-749 
504 |a Ferreira, A.O., (1990) Rev. Soc. Bras. Med. Trop., 23, pp. 209-211 
504 |a Nussenzweig, V., Sonntag, R., Biancalana, A., Pedreira de Fleitas, J.L., Amato Neto, V., Kloetzel, J., (1953) Hospital (Rio de Janeiro), 44, pp. 731-744 
504 |a Docampo, R., Moreno, S.N., (1985) J. Rev. Biochem. Toxicol., 7, pp. 159-204 
504 |a Cinque, G.M., Szajnman, S.H., Zhong, L., Docampo, R., Rodriguez, J.B., Gros, E.G., (1998) J. Med. Chem., 41, pp. 1540-1554 
504 |a Unpublished results; Masner, P., Dorn, S., Vogel, W., Kaelin, M., Graf, O., Guenthart, E., (1981) Pr. Nauk. Inst. Chem. Org. Fiz. Politech. Wroclaw, 22, pp. 809-818 
504 |a Kramer, S.J., Law, J.H., (1980) Acc. Chem. Res., 13, pp. 297-303 
504 |a Rodriguez, J.B., Gros, E.G., Stoka, A.M.Z., (1988) Naturforsch. B, 43, pp. 1038-1042 
504 |a Rodriguez, J.B., Gros, E.G., Stoka, A.M.Z., (1989) Naturforsch. B, 44, pp. 983-987 
504 |a Perlawagora-Szumlewicz, A., Petana, W.P., Figueiredo, M.J., (1975) Rev. Inst. Med. Trop., 17, pp. 97-102 
504 |a Stoka, A.M., Rivas, C., Segura, E., Rodriguez, J.B., Gros, E.G.Z., (1990) Naturforsch. B., 45, pp. 96-98 
504 |a Rodriguez, J.B., Gros, E.G., Stoka, A.M., (1991) Bioorg. Med. Chem. Lett., 1, pp. 679-682 
504 |a Vladusic, E.A., Bussmann, L.E., Visconti, P.E., Stoka, A.M., Rodriguez, J.B., Gros, E.G., Charreau, E.H., (1994) J. Steroid. Biochem. Mol. Biol., 50, pp. 181-187 
504 |a Vladusic, E.A., Pignataro, O.P., Bussmann, L.E., Charreau, E.H., (1995) J. Steroid. Biochem. Mol. Biol., 52, pp. 83-90 
504 |a Lowe, G., Droz, A.S., Vilaivan, T., Weaver, G.W., Tweedale, L., Pratt, J.M., Rock, P., Croft, S.L., (1999) J. Med. Chem., 42, pp. 999-1006 
504 |a Farrell, N.P., Williamson, J., Mc.Laren, D.J.M., (1984) Biochem. Pharmacol., 33, pp. 961-971 
504 |a Mesa Valle, C.M., Moraleda-Lindez, V., Craciunescu, D.G., Alonso, M.P., Osuna, A., (1993) Arzneimit.-Forsch./Drug Res., 43 (2), pp. 1010-1013 
504 |a Rodriguez, J.B., Zhong, L., Docampo, R., Gros, E.G., (1996) BioMed. Chem. Lett., 6, pp. 2783-2786 
504 |a Fichera, L., Esteva, M., Wimmer, Z., Rodriguez, J.B., Gros E.G., Z., (1995) Naturforsch. C, 50, pp. 578-580 
504 |a Schvartzapel, A.J., Fichera, L., Esteva, M., Rodriguez, J.B., Gros, E.G., (1995) Helv. Chim. Acta, 78, pp. 1207-1214 
504 |a Schvartzapel, A.J., Zhong, L., Docampo, R., Rodriguez, J.B., Gros, E.G., (1997) J. Med. Chem., 40, pp. 2314-2322 
504 |a Szajnman, S.H., Yan, W., Bailey, B.N., Docampo, R., Elhalem, E., Rodriguez, J.B., (2000) J. Med. Chem., 43, pp. 1826-1840 
504 |a Rodriguez, J.B., Docampo, R., Gros, E.G., (2000) Int. J. Antimicrob. Agents, 13, pp. 215-218 
504 |a Brown, S., Bernardo, M.M., Li, Z.-H., Kotra, L.P., Tanaka, Y., Fridman, R., Mobashery, S., (2000) J. Am. Chem. Soc., 122, pp. 6799-6800 
504 |a Hajduk, P.J., Bures, M., Praestgaard, J., Fesik, S.W., (2000) J. Med. Chem., 43, pp. 3443-3447 
504 |a Rodriguez, J.B., Zhong, L., Docampo, R., Wimmer, Z., Gros, E.G., (1998) Bioorg. Med. Chem. Lett., 8, pp. 3257-3260 
504 |a López Quiroga, I., Cimino, R., Nasser, J.R., Rodriguez, J.B., Unpublished results; Varki, A., (1992) Glycobiology, 2, pp. 25-40 
504 |a Varki, A., (1997) FASEB J., 11, pp. 248-255 
504 |a Colli, W., (1993) FASEB J., 7, pp. 1257-1264 
504 |a Previato, J.O., Andrade, A.F.B., Pessolani, M.C.V., Mendonça Previato, L., (1985) Mol. Biochem. Parasitol., 16, pp. 85-96 
504 |a Cross, G.A.M., Takle, G.B., (1993) Annu. Rev. Microbiol., 47, pp. 385-411 
504 |a Frasch, A.C.C., (2000) Parasitol. Today, 16, pp. 282-286 
504 |a Pereira, M.E.A., (1983) Science, 219, pp. 1444-1446 
504 |a Kipnis, T.L., David, J.R., Alper, C.A., Sheer, A., Dias da Silva, W., (1981) Proc. Natl. Acad. Sci. USA, 78, pp. 602-605 
504 |a Schenkman, S., Eichinger, D., (1993) Parasitol. Today, 9, pp. 218-222 
504 |a Schenkman, S., Jiang, M.-S., Hart, G.W., Nussenzweig, V., (1991) Cell, 65, pp. 1117-1125 
504 |a Schenkman, R.P.F., Vandekerckhove, F., Schenkman, S., (1993) Infect. Immun., 61, pp. 898-902 
504 |a Frevert, U., Schenkman, S., Nussenzweig, V., (1992) Infect. Immun., 60, pp. 2349-2360 
504 |a Ming, M., Chuenkova, M., Ortega-Barria, E., Pereira, M.E.A., (1993) Mol. Biochem Parasitol., 59, pp. 243-252 
504 |a Tomlinson, S., Pontes de Carvalho, L.C., Vanderkerckhove, F., Nussenzweig, V., (1994) J. Immunol., 153, pp. 3141-3147 
504 |a Tomlinson, S., Pontes de Carvalho, L.C., Vanderkerckhove, F., Nussenzweig, V., (1992) Glycobiology, 2, pp. 549-551 
504 |a Yoshida, N., Dorta, M.L., Ferreira, A.T., Oshiro, M.E.M., Mortara, R.A., Acosta-Serrano, A., Favoreto S., Jr., (1997) Mol. Biochem. Parasitol., 84, pp. 57-67 
504 |a Cremona, M.L., Campetella, O., Sanchez, D.O., Frasch, A.C.C., (1999) Glycobiology, 9, pp. 581-587 
504 |a Buschiazzo, A., Tavares, G.A., Campetela, O., Spinelli, S., Cremona, M.L., Paris, G., Amaya, M.F., Alzari, P.M., (2000) EMBO J., 19, pp. 16-24 
504 |a Agusti, R., Couto, A.S., Campetella, O., Frasch, A.C.C., de Lederkremer, R.M., (1998) Mol. Biochem. Parasitol., 97, pp. 123-131 
504 |a Parodi, A.J., Pollevick, G.D., Mautner, M., Buschiazzo, A., Sanchez, D.O., Frasch, A.C.C., (1992) EMBO J., 11, pp. 1705-1710 
504 |a Pollevick, G.D., Affranchino, J.L., Frasch, A.C.C., Sanchez, D.O., (1991) Mol. Biochem. Parasitol., 47, pp. 247-250 
504 |a Cremona, M.L., Sanchez, D.O., Frasch, A.C.C., Campetella, O., (1995) Gene, 160, pp. 123-128 
504 |a Di Noia, J.M., D'Orso, I., Sánchez, D.O., Frasch, A.C.C., (2000) J. Biol. Chem., 275, pp. 10218-10227. , and references cited therein 
504 |a Pollevick, G.D., Di Noia, J.M., Salto, M.L., Lima, C., Leguizamón, M.S., de Lederkremer, R.M., Frasch, A.C.C., (2000) J. Biol. Chem., 275, pp. 27671-27680 
504 |a Silverman, R.B., (1992), The Organic Chemistry of Drug Design and Drug Action, Academic Press: San Diego; Zuccotto, F., Brun, R., Gonzalez-Pacanowska, D., Ruiz-Perez, L.M., Gilbert, I.H., (1999) Bioorg. Med. Chem. Lett., 9, pp. 1463-1468 
504 |a Knighton, D.R., Kan, C.C., Howland, E., Janson, C.A., Hostowska, Z., Welsh, K.M., Matthews, D.A., (1993) Nat. Struct. Biol., 1, pp. 186-194 
504 |a Zuccotto, F., Martin, A.C.R., Laskowski, R.A., Thornton, J.M., Gilbert, I.H., (1998) J. Comp. Aided Mol. Des., 12, pp. 241-257 
504 |a Aronov, A.M., Suresh, S., Buckner, F.S., van Voorhis, W.C., Verlinde, C.L.M.J., Opperdoes, F.R., Hol, W.G., Gelb, M.H., (1999) Proc. Natl. Acad. Sci. USA, 96, pp. 4273-4278 
504 |a Aronov, A.M., Verlinde, C.L., Hol, W.G., Gelb, M.H., (1998) J. Med. Chem., 41, pp. 4790-4799 
520 3 |a Chagas' disease or American trypanosomiasis is considered by the Word Health Organization to be one of the important tropical parasitic diseases worldwide together with malaria and schistosomiasis. The etiologic agent of this illness is the kinetoplastid protozoon Trypanosoma cruzi. The present chemotherapy for the treatment of Chagas' disease remains unsolved. The drugs currently in use are old, ineffective and toxic. Bearing in mind the metabolic differences between the parasite and the mammalian host, some attractive interesting molecular targets for drug design are presented.  |l eng 
593 |a Dept. de Química Organica, Facultad Ciencias Exactas Naturales, Universidad de Buenos Aires, Pabellón 2, RA-1428 Buenos Aires, Argentina 
690 1 0 |a 4 PHENOXYPHENOXYETHYL ALLYL ETHER 
690 1 0 |a 4 PHENOXYPHENOXYETHYL TETRAHYDRO 2H PYRAN 2 YL ETHER 
690 1 0 |a 4 PHENOXYPHENOXYETHYL THIOCYANATE 
690 1 0 |a ANTIINFECTIVE AGENT 
690 1 0 |a ARYLOXYETHYL THIOCYANATE 
690 1 0 |a BENZNIDAZOLE 
690 1 0 |a BENZOIC ACID DERIVATIVE 
690 1 0 |a CRYSTAL VIOLET 
690 1 0 |a DIHYDROFOLATE REDUCTASE INHIBITOR 
690 1 0 |a ENZYME INHIBITOR 
690 1 0 |a ETHER DERIVATIVE 
690 1 0 |a FENOXYCARB 
690 1 0 |a GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE INHIBITOR 
690 1 0 |a M CHLOROPERBENZOIC ACID 
690 1 0 |a METHOTREXATE 
690 1 0 |a N ACETYL 2,3 DIDEHYDRO 2 DEOXYNEURAMINIC ACID 
690 1 0 |a N ACETYLNEURAMINIC ACID DERIVATIVE 
690 1 0 |a NIFURTIMOX 
690 1 0 |a SIALIDASE 
690 1 0 |a THIOCYANIC ACID DERIVATIVE 
690 1 0 |a UNCLASSIFIED DRUG 
690 1 0 |a ANIMAL EXPERIMENT 
690 1 0 |a ANIMAL MODEL 
690 1 0 |a ANOREXIA 
690 1 0 |a ARTICLE 
690 1 0 |a CHAGAS DISEASE 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a DRUG DESIGN 
690 1 0 |a DRUG STRUCTURE 
690 1 0 |a DRUG TARGETING 
690 1 0 |a HOST 
690 1 0 |a HUMAN 
690 1 0 |a KINETOPLAST 
690 1 0 |a MAMMAL 
690 1 0 |a MOLECULAR BIOLOGY 
690 1 0 |a MOUSE 
690 1 0 |a NONHUMAN 
690 1 0 |a PERIPHERAL NEUROPATHY 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a PROTOZOON 
690 1 0 |a SCHISTOSOMIASIS 
690 1 0 |a SKIN ALLERGY 
690 1 0 |a TROPICAL DISEASE 
690 1 0 |a TRYPANOSOMA CRUZI 
690 1 0 |a VOMITING 
690 1 0 |a WORLD HEALTH ORGANIZATION 
690 1 0 |a ANIMALS 
690 1 0 |a ANTIPROTOZOAL AGENTS 
690 1 0 |a CHAGAS DISEASE 
690 1 0 |a DRUG DESIGN 
690 1 0 |a HUMANS 
690 1 0 |a TRYPANOSOMA CRUZI 
650 1 7 |2 spines  |a MALARIA 
773 0 |d 2001  |g v. 7  |h pp. 1105-1116  |k n. 12  |p Curr. Pharm. Des.  |x 13816128  |t Current Pharmaceutical Design 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034945049&doi=10.2174%2f1381612013397555&partnerID=40&md5=672f0863e7b2d480b16614e5bd78f3a7  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.2174/1381612013397555  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_13816128_v7_n12_p1105_Rodriguez  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_13816128_v7_n12_p1105_Rodriguez  |y Registro en la Biblioteca Digital 
961 |a paper_13816128_v7_n12_p1105_Rodriguez  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 81556